Filing Details

Accession Number:
0001493152-20-023174
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-09 11:28:36
Reporting Period:
2020-11-30
Accepted Time:
2020-12-09 11:28:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1335105 Lixte Biotechnology Holdings Inc. LIXT Pharmaceutical Preparations (2834) 202903526
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1704044 Tak Hung Ho Mayfair By The Sea, Tower T8, 1/F,
Unit A, 21 Fo Chun Road
Taipo Nt, K3 SAR
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-11-30 42,105 $4.75 0 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Warrants to Purchase Common Stock Acquisiton 2020-11-30 42,105 $4.75 42,105 $5.70
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
42,105 2020-11-30 2025-11-30 No 4 P Direct
Footnotes
  1. The reporting person acquired 42,105 Units, each Unit consisting of one share of Common Stock and a five year warrant at an exercise price of $5.70 per share. The purchase price for a Unit was $4.75 per Unit.